Medicus Pharma Ltd (MDCX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Medicus Pharma Ltd Stock (MDCX) Company Profile

Medicus Pharma Ltd

Healthcare (1124)

610-540-7515

300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MDCX's Discussions on Twitter

Vergleichen Sie MDCX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MDCX Medicus Pharma Ltd	2.09	53.37M	0	-16.51M	-15.68M	-1.3528
LLY Lilly Eli Co	993.64	879.11B	59.42B	18.41B	6.44B	20.22
JNJ Johnson Johnson	206.54	481.76B	92.15B	25.12B	20.46B	10.36
ABBV Abbvie Inc	225.18	394.11B	59.64B	2.36B	19.68B	1.3253
NVS Novartis Ag Adr	131.19	251.38B	54.45B	14.42B	17.15B	7.333
MRK Merck Co Inc	97.62	240.48B	63.90B	19.05B	13.05B	7.5596

Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten

Finanzdaten der Medicus Pharma Ltd-Aktie (MDCX)

Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd Stock (MDCX) Company Profile

Vergleichen Sie MDCX mit anderen Aktien

Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten

Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - Bluffton Today

Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 - Victorville Daily Press

Medicus Pharma’s Warrant Inducement Agreement Announced - TipRanks

Medicus Pharma Elevates President Carolyn Bonner to CFO as Clinical Pipeline Accelerates - MyChesCo

Medicus Pharma Ltd. To Present at Brookline Capital Markets - Daytona Beach News-Journal

Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE - Daytona Beach News-Journal

Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The Asheville Citizen Times

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject - Daytona Beach News-Journal

Medicus Pharma secures $5.1 million from warrant exercise agreement By Investing.com - Investing.com Nigeria

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Weatherford Democrat

Medicus Pharma Shakes Up Executive Ranks as President Takes on CFO Role - MSN

How Medicus Pharma Ltd. stock reacts to oil prices2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - Newser

How Medicus Pharma Ltd. Equity Warrant stock trades during market volatilityJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser

Is Medicus Pharma Ltd. Equity Warrant stock attractive for retirement portfoliosTrade Risk Report & Free Long-Term Investment Growth Plans - Newser

Medicus Pharma appoints Carolyn Bonner as CFO - Pharmafile

How currency fluctuations impact Medicus Pharma Ltd. stockJuly 2025 Institutional & Momentum Based Trading Ideas - Newser

Medicus Pharma Ltd. Strengthens Leadership and Expands Clinical Trials - MSN

Medicus Pharma promotes president to chief financial officer - Pennsylvania Business Report -

Should I buy Medicus Pharma Ltd. (N460) stock before earnings seasonWeekly Risk Summary & Scalable Portfolio Growth Methods - Newser

Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch - marketscreener.com

How Medicus Pharma Ltd. (N460) stock gains from tech spendingJuly 2025 Setups & Safe Capital Allocation Plans - Newser

How big funds are accumulating Medicus Pharma Ltd. (N460) stockInsider Buying & Technical Confirmation Trade Alerts - Newser

Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosJuly 2025 Pullbacks & Expert Verified Movement Alerts - Newser

Medicus Pharma shares updates on basal cell carcinoma trials - Pharmafile

Medicus Pharma appoints Carolyn Bonner as CFO after Quinlan resigns By Investing.com - Investing.com Canada

Medicus Pharma appoints Bonner as president and CFO following Quinlan’s resignation - Investing.com Australia

Medicus Pharma applies for FDA priority voucher to accelerate SkinJect’s non-invasive BCC therapy - Proactive financial news

Medicus Pharma appoints Carolyn Bonner as president and CFO By Investing.com - Investing.com Nigeria

Medicus Pharma names president Carolyn Bonner as new CFO - Proactive financial news

Medicus Pharma appoints new CFO - MSN

Medicus Pharma appoints Bonner as president and CFO following Quinlan’s resignation By Investing.com - Investing.com South Africa

Medicus Pharma Ltd. Announces CFO Changes - TradingView

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President - ACCESS Newswire

Medicus Pharma appoints Carolyn Bonner as president and CFO - Investing.com

Medicus Pharma appoints Carolyn Bonner as CFO after Quinlan resigns - Investing.com India

Medicus Pharma appoints Carolyn Bonner as chief financial officer in addition to her role as president - marketscreener.com

Will Medicus Pharma Ltd. Equity Warrant stock benefit from infrastructure spendingMarket Risk Report & High Conviction Investment Ideas - BỘ NỘI VỤ

Medicus Pharma files to sell 2.68M common shares for holders - MSN

Finanzdaten der Medicus Pharma Ltd-Aktie (MDCX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MDCX